This content is in French.
Efficacy and safety of enfortumab and pembrolizumab in urothelial carcinoma
19 mars 2024
Until now, no treatment has shown superior efficacy to platinum-based chemotherapy in improving overall survival in patients with treatment-naive locally advanced or metastatic urothelial carcinoma. In this phase 3 clinical…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Thomas Powles et al. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med. 2024 Mar 7;390(10):875-888.
View the source
